U.S. markets closed

Vifor Pharma AG (VIFN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
121.20-0.75 (-0.62%)
At close: 5:31PM CEST
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
1,718,700
1,705,600
1,877,400
1,584,700
1,342,100
Cost of Revenue
685,000
701,200
761,500
648,700
517,900
Gross Profit
1,033,700
1,004,400
1,115,900
936,000
824,200
Operating Expense
709,500
744,100
790,900
708,500
689,900
Operating Income
324,200
260,300
325,000
227,500
134,300
Net Non Operating Interest Income Expense
44,400
-6,300
-12,500
-11,900
-33,700
Pretax Income
380,300
264,700
309,600
269,400
125,600
Tax Provision
49,000
27,100
35,900
25,000
1,600
Net Income Common Stockholders
416,100
359,600
159,100
152,400
1,147,100
Diluted NI Available to Com Stockholders
416,100
359,600
159,100
152,400
1,147,100
Basic EPS
-
5.54
2.45
2.35
17.70
Diluted EPS
-
5.53
2.45
2.34
17.67
Basic Average Shares
-
64,864
64,859
64,849
64,810
Diluted Average Shares
-
65,028
65,050
65,015
64,918
Total Operating Income as Reported
355,300
291,400
325,000
227,400
134,300
Total Expenses
1,394,500
1,445,300
1,552,400
1,357,200
1,207,800
Net Income from Continuing & Discontinued Operation
416,100
359,600
159,100
152,400
1,147,100
Normalized Income
186,207
110,772
159,100
152,400
34,100
Interest Income
38,800
2,300
2,600
1,300
1,000
Interest Expense
-6,500
7,700
9,000
6,800
25,200
Net Interest Income
44,400
-6,300
-12,500
-11,900
-33,700
EBIT
373,800
272,400
318,600
276,200
150,800
EBITDA
595,000
-
-
-
-
Reconciled Cost of Revenue
685,000
701,200
761,500
648,700
517,900
Reconciled Depreciation
221,200
284,400
215,000
164,100
146,000
Net Income from Continuing Operation Net Minority Interest
213,300
138,700
159,100
152,400
34,100
Total Unusual Items Excluding Goodwill
31,100
31,100
10,700
10,500
16,000
Total Unusual Items
31,100
31,100
10,700
10,500
16,000
Normalized EBITDA
563,900
525,700
533,600
440,300
296,800
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,007
3,172
0
0
0